Why the study?
Does pre-existing cardiac hypertrophy differentially modulate the responses of male and female cardiomyocytes to ischemic and adrenergic stress?
Does pre-existing cardiac hypertrophy differentially modulate the responses of male and female cardiomyocytes to ischemic and adrenergic stress?
Cardiac hypertrophy produces dramatically different basal and stress-induced pathophenotypes in female- and male-origin cardiomyocytes, highlighting the need for sex-specific post-ischemic support strategies.
No takes yet. Share an insight, caveat, or question.
Sex-specific cardiomyocyte responses to ischemia in hypertrophy warrant caution in women; leaves open clinical translation and targeted trials.
Bell et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: